Limpid Markets
← Back to Intelligence

Vanda Pharmaceuticals shares rise on Nereus commercial launch

Investing.com Gold Tier 2 2026-05-04 19:35 UTC 📖 1 min read Neutral

Investing.com Gold reports: Vanda Pharmaceuticals shares rise on Nereus commercial launch. Full body text was unavailable at ingest time, so this brief is based on headline context.

↗ Read Original